Home > Insider Trading > Filing (0000950170-25-098528)

Filing Details

Accession Number:: 0000950170-25-098528
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-07-24 20:25:31
Reporting Period:: 2025-07-22

Filing Date:: 2025-07-24
Accepted Time:: 2025-07-24 20:25:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1794546	Carlsmed Inc.	CARL	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1048637	M Philip Young	C/O Carlsmed, Inc. 1800 Aston Ave., Suite 100 Carlsbad CA 92008		No	No	No	No

Transaction Summary

Purchased:	59,999 shares	Avg. Price: $15.00	Total Value: $899,985.00
Number of Shares After Transactions:	53,333 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-07-22	17,333	$0.00	17,333	No	4	A	Direct
Common Stock	Acquisiton	2025-07-24	28,900	$0.00	28,900	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2025-07-24	6,666	$15.00	35,566	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2025-07-24	53,333	$15.00	53,333	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	C	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2025-07-24	28,900	$0.00	28,900	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Constitute an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years.
Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock.
These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.
Stock held by PMY Partners LP.
Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.
Includes 6,666 shares of the Issuer's common stock purchased by PMY Partners L.P. in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering.
(7) Includes (i) 6,666 shares of the Issuer's common stock purchased by PMY Partners L.P. in the Issuer's initial public offering at the public offering price of $15.00 per share, and (ii) 28,900 shares of common stock issued to PMY Partners L.P. upon the conversion of outstanding preferred stock on a 1-to-1 basis, immediately prior to the closing of the Issuer's public offering.
Includes 53,333 shares of the Issuer's common stock purchased by the Young Family Trust dtd 04/13/1998 Nancy Halsey Young & Philip Young, Trustees (the "Trust") in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering.
Stock held by the Trust.
Reporting Person is a trustee of the Trust and has voting and dispositive power over the stock held by the Trust.